MEGATAS 50 MG 10 Tablets

Megatas 50 

Megatas 50 belongs to a class of drugs known as ‘urinary antagonists’ or ‘antispasmodics,’ which are principally used to treat the symptoms of overactive bladder (OAB). Overactive bladder is a disorder in which the muscles of the urinary bladder constrict involuntarily, resulting in an urgent need to urinate, frequent urine, and difficulty to control urination.

Megatas 50 contains’mirabegron,’ which relaxes the muscles of the urine bladder, reducing the activity of an overactive bladder. Muscle contractions occur before the bladder fully expands in an overactive bladder, causing the patient to have frequent urges to urinate. Megatas 50 inhibits these rapid spasms of the urinary bladder muscles, allowing for better urine control. As a result, it increases the amount and volume of pee that your bladder can hold.

Megatas 50 should be taken according to your doctor’s instructions. With a full glass of water, swallow it whole. It should not be chewed, crushed, or broken. Megatas 50 is a supplement that can be taken with or without food. Nausea, constipation, diarrhea, headache, dizziness, and an elevated heart rate are all common Megatas 50 side effects. If these adverse effects persist or worsen, contact your doctor.

If you’re allergic to any of the other ingredients in Megatas 50, don’t take it. If you have renal illness, liver disease, hypertension, urinary retention, angioedema, or a history of cardiac rhythm difficulties, tell your doctor before using Megatas 50. (including QT prolongation). Also, let your doctor know if you’re pregnant or nursing. Notify your physician. This drug may induce dizziness, so don’t drive or use heavy machinery while taking it.

Megatas 50 is used to treat overactive bladder (urinary incontinency).

Medicinal Advantages

Megatas 50 contains a substance known as’mirabegron,’ which belongs to the anticholinergic drug class. It has the ability to reduce the activity of an overactive bladder. Muscle contractions occur before the bladder fully expands in an overactive bladder, causing the patient to have frequent urges to urinate. Megatas 50 can help to stop these uncontrollable bladder muscle contractions. It gives you more control over urination and increases the volume of urine your bladder can hold.

Use Instructions

Take Megatas 50 at the dose and for the duration recommended by your doctor. With a glass of water, swallow it whole. It should not be chewed, crushed, or broken. Megatas 50 can be taken with or without food, however it’s best if you take it at the same time every day.

Store in a cool, dry location away from direct sunlight.

Megatas 50 Side Effects

Constipation

Headache

Blood pressure that is too high

Inflammation of the nose

Infection of the urinary tract

Drug Recommendations

If you are allergic to any of the other ingredients in Mirabegron, do not take it. If you have renal illness, liver disease, hypertension, urinary retention, angioedema, or a history of heart rhythm difficulties, tell your doctor before using Mirabegron (including QT prolongation). Also, let your doctor know if you’re pregnant or nursing. Notify your physician. This drug may induce dizziness, so don’t drive or use heavy machinery while taking it.

Interactions Between Drugs

Antihypertensives (carvedilol, metoprolol), antacid (brexpiprazole), anti-psycotic (pimozide, thioridazine), anti-allergic (chlorpheniramine), anti-tussive (dextromethorphan), blood thinners (warfarin, coumadin), anti-depressants (desipramine), anti-arrhythmics (digoxin, fleca (darifenacin, fesoterodine, oxybutynin, tolterodine, trospium),

While taking Mirabegron, avoid eating grapefruit or drinking grapefruit juice.

In individuals with bladder retention (inability to pee), heart rhythm disorders (including QT prolongation), hypertension, renal dialysis, severe liver disease, and severe kidney illness, Mirabegron should be taken with caution.

Safety Suggestions

ALCOHOL

Alcohol should be avoided because it raises the chance of side effects.

PREGNANCY

Mirabegron should only be used if absolutely essential in pregnant women. Before using this prescription, talk to your doctor about all of the dangers and benefits.

BREAST FEEDING

Mirabegron should only be used if absolutely necessary in breastfeeding women. Before using this prescription, talk to your doctor about all of the dangers and benefits. If this medicine is used, it is important that the infant be closely monitored for any unwanted side effects.

DRIVING

Some people may experience blurred vision or dizziness as a result of taking this medication. If you have any of these symptoms while taking this prescription, it is recommended that you avoid doing things like driving a car or operating machinery.

KIDNEY

In patients with severe kidney disease, Mirabegron should be administered with caution. Mirabegron dosage may need to be adjusted. Please seek medical advice.

LIVER

In people with liver illness, mirabegron should be taken with caution. Mirabegron dosage may need to be adjusted. Please seek medical advice. In patients with severe liver disease, Mirabegron should not be used.

No habit formation

Advice on Diet and Lifestyle

Fresh fruits such as pears, bananas, and citrus fruits, as well as green vegetables such as beans and potatoes, should be consumed.

Cranberry juice is beneficial for preventing urinary infections.

Caffeine-containing beverages such as coffee, tea, and fizzy beverages should be avoided.

Processed, fried, or spicy foods should be avoided because they can irritate your bladder.

Alcohol consumption should be limited because it can raise the likelihood of negative effects.

Quit smoking and get some exercise on a regular basis.

Recommendations

Because Mirabegron might produce blurry vision and dizziness, it’s best to avoid driving a car, using heavy machinery, and other dangerous occupations that need mental attention.

Mirabegron may cause an increase in blood pressure. Regularly check your blood pressure.

Additional Information: This item is non-refundable.

Concerns of Patients

In normal circumstances, when the urinary bladder is filled with pee, it sends a signal to the brain that the person is ready to urinate. The bladder muscles contract during the urinating process, resulting in a consistent flow of urine. In contrast, in Overactive Bladder (OAB), the urinary bladder muscles begin to contract before the bladder has full with pee, resulting in frequent desires to urinate. Mirabegron works by preventing abrupt bladder muscle contractions and boosting the bladder’s capacity to store more pee. As a result, Mirabegron aids in the management of urine release and aids in the reduction of OAB symptoms such as a strong urge to urinate, frequent urination, and lower urine flow.

FAQs

Mirabegron is used to treat an overactive bladder, which is characterized by an inability to control urine and a constant desire to urinate. Mirabegron reduces the volume and amount of urine that the bladder can store by preventing abrupt bladder muscle contractions. As a result, Mirabegron aids in the management of urine release and aids in the reduction of OAB symptoms such as a strong urge to urinate, frequent urination, and lower urine flow.

Nausea, constipation, diarrhea, headache, dizziness, and an elevated heart rate are all common Mirabegron adverse effects. If these adverse effects persist or worsen, contact your doctor.

Please see your doctor before taking Mirabegron if you have renal illness, liver disease, hypertension, urinary retention, angioedema, or a history of cardiac rhythm disorders (including QT prolongation).

Mirabegron may interact with ketoconazole, an antifungal medication. To avoid side effects, tell your doctor about all of your prescription and non-prescription medications before using Mirabegron.

Because of the increased risk of the patient’s condition worsening, Mirabegron should be administered with caution in individuals with high blood pressure. In patients with severe uncontrolled hypertension, it is not indicated. In some circumstances, dependent on the clinical condition, regular blood pressure monitoring, appropriate dose modifications, or replacement with a suitable alternative may be required.